These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37329814)

  • 1. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer's disease.
    Yan N; Xie F; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
    Bioorg Chem; 2023 Sep; 138():106663. PubMed ID: 37329814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of thieno[3,2-
    Yan N; Shi XL; Tang LQ; Wang DF; Li X; Liu C; Liu ZP
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1724-1736. PubMed ID: 35698879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
    Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
    Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
    Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
    Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.
    Liang Z; Li QX
    ACS Chem Neurosci; 2018 May; 9(5):1166-1183. PubMed ID: 29381861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth.
    Shi XL; Yan N; Cui YJ; Liu ZP
    Cells; 2020 Mar; 9(3):. PubMed ID: 32155989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Structure-Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-
    Hartz RA; Ahuja VT; Sivaprakasam P; Xiao H; Krause CM; Clarke WJ; Kish K; Lewis H; Szapiel N; Ravirala R; Mutalik S; Nakmode D; Shah D; Burton CR; Macor JE; Dubowchik GM
    J Med Chem; 2023 Mar; 66(6):4231-4252. PubMed ID: 36950863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and bioevaluation of 1,2,4-thiadiazolidine-3,5-dione derivatives as potential GSK-3β inhibitors for the treatment of Alzheimer's disease.
    Dong Y; Lu J; Zhang S; Chen L; Wen J; Wang F; Mao Y; Li L; Zhang J; Liao S; Dong L
    Bioorg Chem; 2023 May; 134():106446. PubMed ID: 36868127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPPU protects tau from H
    Yao ES; Tang Y; Liu XH; Wang MH
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer's Disease-Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors.
    Góral I; Wichur T; Sługocka E; Godyń J; Szałaj N; Zaręba P; Głuch-Lutwin M; Mordyl B; Panek D; Więckowska A
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringin Protects against Tau Hyperphosphorylation in A
    Qiu Q; Lei X; Wang Y; Xiong H; Xu Y; Sun H; Xu H; Zhang N
    Behav Neurol; 2023; 2023():1857330. PubMed ID: 36844418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
    Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
    Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease.
    Luo Z; Li S; Zhang Y; Yin F; Luo H; Chen X; Cui N; Wan S; Li X; Kong L; Wang X
    Eur J Med Chem; 2023 Aug; 256():115415. PubMed ID: 37172476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.